Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "Acinetobacter Infections"
Show Display Options
Rank Status Study
1 Active, not recruiting Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections
Condition: Acinetobacter Infections
Intervention: Drug: Sulbactam
2 Completed Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical
Condition: Acinetobacter Infections
Interventions: Drug: Colistin;   Drug: Tigecycline;   Drug: Vancomycin
3 Recruiting Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
Condition: Acinetobacter Infections
Intervention: Drug: colistimethate sodium
4 Active, not recruiting Clinical Outcomes and Global Epidemiology -Data Coordinating Center
Condition: Acinetobacter Infections
Intervention:
5 Recruiting Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol
Condition: Acinetobacter Infections
Intervention:
6 Active, not recruiting Risk Factors for Carbapenem-resistant Acinetobacter Baumannii
Condition: Acinetobacter Infections
Intervention:

Indicates status has not been verified in more than two years